Search

everythinglearnresearchcommunity

for

Search:↓

Putting calcipotriol ointment on the skin once doesn't change calcium levels in the body right away.

Alopecia patients have less GPER-1, which might affect hair loss.

Microneedling combined with platelet-rich plasma therapy is more effective for hair regrowth in androgenic alopecia than microneedling alone, but it's more painful.

Finasteride may effectively treat hair loss in Klinefelter Syndrome patients.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Using your own platelet-rich plasma (PRP) can effectively treat hair loss, increasing hair density and width with no side effects.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

Finasteride helps female-pattern hair loss.

Iron and zinc deficiencies may be treated to help female hair loss.

Detailed history and physical examination are crucial for diagnosing hair loss.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

White females have higher hair density, while Asian females have thicker hair in hair loss cases.

Finasteride and low-level laser therapy are similarly effective for frontal pattern hair loss.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Minoxidil, finasteride, and hair transplantation combined give best results for hair loss.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

New therapy helps treat hair loss.

New therapy helps treat hair loss.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.